K150660 is an FDA 510(k) clearance for the Alcyone MEMS Cannula (AMC) System. Classified as Cannula, Ventricular (product code HCD), Class I - General Controls.
Submitted by Alcyone Lifesciences, Inc. (Lowell, US). The FDA issued a Cleared decision on April 16, 2015 after a review of 34 days - a notably fast clearance cycle.
This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4060 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Alcyone Lifesciences, Inc. devices